| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $194K | -24.7% |
| SG&A Expense | $365K | -26.3% |
| Operating Income | -$630K | +21.5% |
| Interest Expense | $136K | -35.1% |
| Net Income | -$734K | +31.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | -91.2% |
| Current Assets | $3K | -91.2% |
| Total Assets | $3K | -91.2% |
| Current Liabilities | $1.3M | +12.7% |
| Total Liabilities | $1.3M | +12.7% |
| Stockholders' Equity | -$1.3M | -16.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104K | +14.7% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $73K | -27.5% |